Yoshinobu Saito

10PUBLICATIONS
61CO-AUTHORS
Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Health counsellingHaematological tumoursRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 11, 2026
Proteomic Analysis of Serum Extracellular Vesicles Revealed Fibulin-3 as a Novel Predictive Biomarker for Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.

|Mar 24, 2026
Impact of Treatment Response to Anticoagulant Therapy on Liver-Related Events in Patients With Cirrhosis and Portal Vein Thrombosis.

Atsushi Maeda, Yuki Tahata, Hayato Hikita

|Sep 18, 2025
Serum Growth Differentiation Factor 15 Can Be a Novel Biomarker to Predict the Prognosis of Patients With Hepatitis C Virus Cirrhosis After Virus Elimination.

Yuta Myojin, Hayato Hikita, Yuki Tahata

|Jun 16, 2025
The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long-Term Administration of Nucleos(t)ide Analogs.

Kazuhiro Murai, Hayato Hikita, Ryoko Yamada

|Mar 13, 2025
Hepatic stellate cells control liver zonation, size and functions via R-spondin 3.

Atsushi Sugimoto, Yoshinobu Saito, Guanxiong Wang

|Feb 24, 2025
Collaborative orchestration of BH3-only proteins governs Bak/Bax-dependent hepatocyte apoptosis under antiapoptotic protein-deficiency in mice.

Shinnosuke Kudo, Hayato Hikita, Yoshinobu Saito

Pageof 2

Frequent Collaborators

6 joint publications

Takahiro Kodama

5 joint publications

Ryotaro Sakamori

4 joint publications

Hayato Hikita

4 joint publications

Yuki Tahata